CD8A and neoplasm: T cell Ig and immune receptor tyrosine inhibitory motif (ITIM) structural domains (TIGIT) acts as an immune checkpoint that is highly expressed on the surface of natural killer cells (NK) and T cells, significantly limiting anti-tumor and other CD8+ T cell-dependent chronic immune responses (19–21).